Mass Spectrometry-Based Tissue Imaging of the Tumor Microenvironment
Tyler Risom, Patrick Chang, Sandra Rost et al. · Methods in molecular biology · 2023
Cited by 3 works. doi:10.1007/978-1-0716-3163-8_12
Authors
References
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- Biomarkers for epithelial-mesenchymal transitions
- Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- Dynamics of the Immune Reaction to Pancreatic Cancer from Inception to Invasion
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
- Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
- Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
- Synthesis of a Functional Metal-Chelating Polymer and Steps toward Quantitative Mass Cytometry Bioassays
- Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma